Businesses in any industry can dramatically improve their understanding of what drives the customer buying decision with Pricing Research & Analytics. Armed with greater insights, our healthcare clients in the UK and Europe execute value-driven Pricing Strategies that optimize profits.

In the healthcare, medtech, pharmaceutical and life sciences sectors, that means building pricing strategy around a solid understanding of the complete decision-making process, which typically includes the roles of clinicians, payers, KOLs and patients.

Overall, we look at product value, competition, payer strategies and willingness-to-pay.

As one of the world’s leading pricing consultancies, it is our mission to dramatically improve client’s profitability and market share through pricing. You already know the power of pricing research. Let us show you the Pricing Solutions difference: Send us your RFP

Value-based Pricing

• Identifying key value drivers for specific indications/diseases
• Assessing the product value against key value drivers
• Assessing the comparative value vs. competitor products
• Identifying clinical barriers to prescribing

Pricing, Reimbursement & Market Access

• Establishing possible product evaluation processes
• Identifying key decision stakeholders
• Establishing an optimal strategy to gain market access across markets
• Understanding price/volume relationship based on access and prescribing
• Identify optimal price by country and launch sequencing or global pricing strategy

Our healthcare clients in Europe and the UK achieve a typical payback of 10:1 on their research investment by leveraging pricing during various points in a product’s development cycle, including: Ideation, Prototyping, Beta Testing and Pre-Launch when faced with specific product pricing and value challenges.

Global Pricing and Value Research in Healthcare

In the healthcare sector, it is critical to understand each element in an often complicated decision making process. These include the payer decision making, doctor treatment protocols and patient journeys.

Taking a More Active Role in Paying for Healthcare

Expensive drugs, limited coverage by private and public payers, online technologies and the growth of personalised medicine are some of the factors encouraging Canadians, especially older, middle-class Canadians, to take a more active role in paying for their healthcare

Trust the Process of High Pharma Prices to Incentivize Innovation and Competition

High prices for pharmaceuticals are on the minds of many of the payers and clinicians that I speak with during pricing research projects. Such high prices should encourage innovation and competition, and once a specific unmet need has been addressed, the price of treating that specific medical problem will likely come down over time.

Pricing Research for the Changing Pharma Sector

Based on our experience of conducting pricing research in the pharmaceutical space, as well as being part of the pharmaceutical market research community for the past 20 years, it is striking how much the pharmaceutical sector has changed, and continues to change.